tm logo

Monitor this mark

View On USPTO

ALLOCAR T
Live/Registered
CANCELLATION PENDING

on 30 Aug 2024

Last Applicant/ Owned by

Allogene Therapeutics, Inc.

210 E. Grand Avenue

South San Francisco

CA

94080

Serial Number

97889420 filed on 14th Apr 2023

Registration Number

7307152 registered on 13th Feb 2024

in the Supplemental Register

Correspondent Address

THOMAS L. HOLT

THOMAS L. HOLT PERKINS COIE LLP

SEATTLE, WA 98111

UNITED STATES

Filing Basis

1. filed as use application

2. use application currently

Disclaimer

NO DATA

ALLOCAR T

Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical preparations, namely, preparations for use in the treatment of cancer and tumors; pharmaceutical and biological preparations for immunotherapy, including T Cell therapy

First Use Date in General

13th Jul 2021

First Use Date in Commerce

13th Jul 2021

Mark Details

Serial Number

No 97889420

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
30th Aug 2024CANCELLATION INSTITUTED NO. 999999
13th Feb 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
13th Feb 2024REGISTERED-SUPPLEMENTAL REGISTER
10th Jan 2024APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
10th Jan 2024LETTER OF PROTEST EVIDENCE REVIEWED-NO FURTHER ACTION TAKEN
10th Jan 2024ASSIGNED TO EXAMINER
31st Dec 2023PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
31st Dec 2023ASSIGNED TO LIE
02th Aug 2023TEAS VOLUNTARY AMENDMENT RECEIVED
28th Jun 2023LETTER OF PROTEST EVIDENCE FORWARDED